Advertisement
Several factors will be integral in facilitating growth in this market,including increased adoption of Synthes Spine's and Medtronic Spinal andBiologics' cervical artificial discs in the US, the release of newly designedproducts from numerous different competitors, a familiar surgical approach tothat of anterior cervical fusion, as well as an increased use of multiplediscs in a single procedure.
Advertisement
"Both patients and surgeons alike are excited about cervical artificialdisc technology," says Kevin Flewwelling, Manager of MRG's Orthopedicsdivision. "Patients benefit from the increased motion preservation associatedwith cervical artificial discs, as well as the shorter recovery times, whichenables them to return quickly to their regular lifestyles. Surgeons, on theother hand, are comfortable with the surgical technique and are attracted bythe technologies' ability to restore physiological motion and minimizeadjacent-level disc disease."
The Global Markets for Spinal Nonfusion Technologies 2008 report coversthe artificial disc, dynamic stabilization, nuclear disc replacement, annulusrepair, and facet arthroplasty markets. Industry competitors include AbbottSpine, Aesculap Implant Systems, Anulex Technologies, Biomet Spine, Cervitech,DePuy Spine, LDR Spine, Medtronic Spinal and Biologics/Kyphon, NuVasive,Paradigm Spine, Raymedica, Scient'x, SpineVision, Stryker Spine, SynthesSpine, Trans1, and Zimmer Spine.
About Cervical Artificial Discs
With age, intervertebral discs may begin to dehydrate and lose theirability to retain water, contributing to severe pain and decreased mobility.Artificial discs were developed to treat chronic back pain while allowing forthe preservation of physiological vertebral motion through properintervertebral spacing and stability.
About Millennium Research Group
Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc.company (http://www.DecisionResources.com), is the global authority on medicaltechnology market intelligence and a leading provider of strategic informationto the health care sector. Focused solely on the medical device,pharmaceutical, and biotechnology industries, the company provides its clientswith the benefits of its specialized industry expertise through publishedreports and customized consulting services.
All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Amy Krohn Millennium Research Group 416-364-7776 x101 [email protected]
SOURCE Millennium Research Group
